A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 5, 1997, Pages 425-432

  Narasaki, Fumihiko ^a   Oka, Mikio ^a   Fukuda, Minoru ^a   Nakano, Reiji ^a   Ikeda, Koki ^a   Takatani, Hiroshi ^a   Terashi, Kenji ^a   Soda, Hiroshi ^a   Yano, Osamu ^b   Nakamura, Tsuyoshi ^a   Doyle, L Austin ^c   Tsuruo, Takashi ^d   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Mitsui Pharmaceuticals Inc   (Japan)

^c UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Lung cancer; MRP; MS 209; Multidrug resistance; Reversal drug

Indexed keywords

5 [3 (4 DIPHENYLACETYL 1 PIPERAZINYL) 2 HYDROXYPROPOXY]QUINOLINE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; LUNG SMALL CELL CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LUNG NEOPLASMS; QUINOLINES; TUMOR CELLS, CULTURED;

EID: 8544257004     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050681     Document Type: Article

References (47)

1. Arcari P, Martinelli R, Salvatore F (1984) The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucl Acids Res 12: 9179
2. Baba M, Nakanishi O, Sato W, Saito A, Miyama Y, Yano O, Shimada S, Fukazawa N, Naito M, Tsuruo T (1995) Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells. Cancer Chemother Pharmacol 36: 361
3. Barrand MA, Rhodes T, Center MS, Twentyman PR (1993) Chemosensitization and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur J Cancer 29: 408
4. Barrand MA, Heppell-Parton AC, Wright KA, Rabbitts PH, Twentyman PR (1994) A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J Natl Cancer Inst 86: 110
5. Bartlett NL, Lum BL, Fisher GA, Brophy NA, Ehsan MN, Halsey J, Sikik BI (1994) Phase I trial of doxorubicin with cyclosporin as a modulator of multidrug resistance. J Clin Oncol 12: 835
6. Beketic-Oreskovic L, Durán GE, Chen G, Dumontet C, Sikic BI (1995) Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. J Natl Cancer Inst 87: 1593
7. Bellamy WT, Dalton WS (1994) Multidrug resistance in the laboratory and clinic. Adv Clin Chem 31:1
8. Berg SL, Tolcher A, O'Shaughnessy JA, Denicoff AM, Noone M, Ognibene FP, Cowan KH, Balis FM (1995) Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancer. J Clin Oncol 13: 2039
9. Breuninger LM, Paul S, Gaugham K, Miki T, Chan A, Aaronson SA, Kruh GD (1995) Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 55: 5342
10. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156
11. Cole SPC, Deeley RG (1993) Multidrug resistance-associated protein: sequence correction. Science 260: 879
12. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650
13. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902
14. Dalton WS (1993) Drug resistance modulation in the laboratory and the clinic. Semin Oncol 20: 64
15. Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Belani CP, Gutheil JC (1995) An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Br J Cancer 72: 535
16. Fairchild CR, Ivy SP, Kao-Shan C-S, Whang-Peng J, Rosen N, Israel MA, Melara PW, Cowan KH, Goldsmith ME (1987) Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 47: 5141
17. Fisher GA, Sikic BI (1995) Clinical studies with modulators of multidrug resistance. Hematol Oncol Clin North Am 9: 363
18. Ford JM, Hait WN (1993) Pharmacologic circumvention of multidrug resistance. Cytotechnology 12: 171
19. Fukazawa N, Odate M, Suzuki T, Otsuka K, Sato W, Tsuruo T (1989) Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components. European Patent Publication No. 0363212
20. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385
21. Graaf WTA van der, Vries EGE de, Timmer-Bosscha H, Meersma GJ, Mesander G, Vellanga E, Mulder NH (1994) Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines. Cancer Res 54: 5368
22. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357
23. Ihde DC (1992) Chemotherapy of lung cancer. N Engl J Med 327: 1434
24. Ishikawa T, Tien Kuo M, Priebe W, Suzuki M (1996) Response to correspondence. How does the MRP/GS-X pump export doxorubicin? J Natl Cancer Inst 88: 466
25. Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54: 4833
26. Krishnamachary N, Center MS (1993) The MRP gene with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658
27. Kruh GD, Chan A, Myers K, Gaughan K, Miki T, Aaronson SA (1994) Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res 54: 1649
28. List AF, Spier C, Greer J, Wolff S, Hutter J, Dorr R, Salmon S, Futscher B, Baier M, Dalton W (1993) Phase I/II trial of cyclosporin as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 11: 1652
29. Liu RJ (1993) Chemotherapy outcomes in advanced non-small-cell lung carcinoma. SeminOncol 20: 296
30. Loe DW, Almquist KC, Deeley RG, Cole SPC (1996) Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. J Biol Chem 271: 9675
31. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55
32. Müller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mülder NH, de Vries EGE, Jansen PLM (1994) Overexpression of the multidrug resistance associated protein (MRP) gene results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91: 13033
33. Narasaki F, Matsuo I, Ikuno N, Fukuda M, Soda H, Oka M (1996) Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res 16: 2079
34. Pastan I, Gottesman MM (1987) Multiple-drug resistance in human cancer. N Engl J Med 316: 1388
35. Raderer M, Scheithauer W (1993) Clinical trials of agents that reverse multidrug resistance (review). Cancer 72: 3553
36. Sato W, Fukazawa N, Suzuki T, Yusa K, Tsuruo T (1991) Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073. Cancer Res 51: 2420
37. Sato W, Fukazawa N, Nakanishi O, Baba M, Suzuki T, Yano O, Naito M, Tsuruo T (1995) Reversal of multidrug resistance by novel quinoline derivative, MS-209. Cancer Chemother Pharmacol 35: 271
38. Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH (1994) Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54: 152
39. Sikic BI (1993) Modulation of multidrug resistance: at the threshold. J Clin Oncol 11: 1629
40. Slapak CA, Mizunuma N, Kufe DW (1994) Simultaneous overexpression of P-glycoprotein and the multidrug-resistance associated protein (MRP) in doxorubicin-selected human myeloid leukemia cells. Blood 84: 3113
41. Stiff PJ, Bayer R, Tan S, Camarda M, Sosman J, Peace D, Kinch L, Rad N, Loutfi S (1995) High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial. Clin Cancer Res 1: 1495
42. Tsuruo T (1994) MDR reversing drugs for clinical development. Jpn J Cancer Chemother 21: 962
43. Ueda K, Cardarelli C, Gottesman MM, Pastan I (1992) Expression of a full-length cDNA for the human mdr1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84: 3004
44. Wilson WH, Bates SE, Fojo A, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, Chabner BA (1995) Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. J Clin Oncol 13: 1995
45. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas F, Borst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53: 1747
46. Zaman GJR, Flens MJ, Leusden MR van, Haas M de, Mülder NH, Lankelma J, Pinedo HM, Vries EGE de, Scheper RJ, Baas F, Broxterman HJ, Borst P (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822
47. Zaman GJR, Lankelma J, Tellingen O van, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92: 7690